VIM
ELV icon

VELA Investment Management’s Elevance Health ELV Stock Holding History

VELA Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,674
Closed -$1.04M – 179
2025
Q2 		$1.04M Hold
2,674
– – 0.28% 102
2025
Q1 		$1.16M Buy
2,674
+600
+29% +$241K 0.36% 90
2024
Q4 		$765K Buy
2,074
+1,045
+102% +$437K 0.21% 119
2024
Q3 		$535K Hold
1,029
– – 0.17% 133
2024
Q2 		$558K Hold
1,029
– – 0.17% 127
2024
Q1 		$534K Buy
1,029
+11
+1% +$5.47K 0.18% 130
2023
Q4 		$480K Hold
1,018
– – 0.18% 128
2023
Q3 		$443K Buy
+1,018
New +$462K 0.19% 114

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VELA Investment Management's ELV Position: Q3 2025 in Review

VELA Investment Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 2,674 shares — an estimated $1.04M sold.

VELA Investment Management first reported a position in ELV in Q3 2023 and held it in 8 quarters. The position peaked at $1.16M in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • VELA Investment Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • VELA Investment Management sold 2,674 Elevance Health shares in Q3 2025, an estimated $1.04M.
  • VELA Investment Management first reported a position in Elevance Health in Q3 2023 and held it in 8 quarters.
  • VELA Investment Management's Elevance Health position peaked at $1.16M in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on VELA Investment Management's 13F filing for Q3 2025, filed 30 Oct 2025.